期刊文献+

Carbogen对肿瘤乏氧的改善以及在^(32)P间质内放疗中的作用

Study on improvement of tumor hypoxia and 32P-colloid interstitial treatment effect by lasting inhalation of carbogen
原文传递
导出
摘要 目的研究Carbogen长时间吸入的安全性,对肿瘤乏氧的改善以及对32P肿瘤间质内放疗疗效的影响。方法①荷S180肿瘤小鼠10只,行吸入Carbogen前、后的99mTcHL91SPECT乏氧显像,比较两者TNT的变化。②正常小鼠20只,分为对照组和Carbogen吸入组,后者每日吸Carbogen2h,共24d。观察小鼠的日常活动、体重变化,及重要脏器病理学变化。③荷S180肿瘤小鼠40只,分为未治疗空气组、未治疗Carbogen组、32P治疗空气组、32P治疗Carbogen组,观察、对比各组小鼠肿瘤生长情况,检测抑瘤率和抑瘤曲线。结果①Carbogen吸入前后肿瘤99mTcHL91的TNT分别为1.872±0.391和1.354±0.189,差异有统计学意义(t=4.476,P<0.01);②未治疗空气组、未治疗Carbogen组小鼠间肿瘤生长速率无明显区别;32P治疗空气组、32P治疗Carbogen组小鼠在治疗后第12天抑瘤率分别为66.01%和69.43%,两者间无明显区别,在治疗后第24天,肿瘤体积分别为(2.728±0.469)和(2.237±0.603)cm3(t=2.128,P<0.05),肿瘤质量分别为(2.437±0.447)和(1.965±0.538)g(t=2.134,P<0.05)。③正常小鼠Carbogen长期吸入后日常活动、体重变化等与正常对照组间无明显区别,心、脑、肺、肝、脾、肾、小肠等脏器未见明显异常病理学改变。结论Carbogen可以明显改善肿瘤乏氧状况,中长期吸入对小鼠毒副作用较小,在一定程度上可以增加32P肿瘤间质内放疗的疗效。 Objective To study the safety and improvement in tumor hypoxia and the ^32 P-colloid interstitial treatment effect with lasting earbogen-inhaling in murine tumor models. Methods 1. The ^99m Tc-HL91 SPECT imaging was performed in 10 S180 tumor-bearing mice before and after carbogen inhalation for 2 hours; 2. Twenty normal BALB/c mice were divided into an air-group and a carbogen-group, in which carbogen was inhaled by mice 2 hours per day for 24 days. The activity body weight were observed, and pathologic examination of important organs was taken; 3. Forty miee bearing S180 tumor were divided into four groups: untreated air-inhaling group, untreated carbogen-group, ^32 P-treated air-inhaling group, ^32 P-treated carbogeninhaling group. The volume of tumors and tumor inhibition curves were measured and compared in all mice, and the tumor inhibition ratio was calculated. Results 1. The TINT of ^99m Tc-HL91 before and after carbogen inhalation was 1.872 ±0.391 and 1.354 ± 0. 189, respectively ( t = 4.476, P 〈 0.01 ) ; 2. The tumor volume was not different between miee of untreated air-inhaling group and untreated earbogen-inhaling group; The tumor inhibition ratio was 66.01% and 69.43 % respectively in the mice of ^32 P-treated, air-inhaling group and ^32P-treated, earbogen-inhaling group on day 12 alter ^32 P-eolloid interstitial treatment, whereas on day 24 the tumor volume was 2.728±0.469 cm^3 and (2.237±0.603) cm^3(t = 2. 128, P〈0.05) and the tumor mass was 2.437 ± 0.447 and ( 1.965 ± 0.538)g ( t = 2. 134, P 〈 0.05) ; 3. There were no differences in the activity, body weight between untreated air-inhaling mice and untreated carbogen-inhaling mice. No abnormal pathologic ehanges of important organs were found in untreated earbogen inhalation miee. Conclusion Long-term carbogen inhalation could significantly improve tumor hypoxia and ^32 P-celloid interstitial treatment effect, and no toxicity was observed in mice.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2005年第5期437-440,共4页 Chinese Journal of Radiological Medicine and Protection
关键词 CARBOGEN ^32P间质内放疗 放射性核素 放射治疗 肿瘤 乏氧区域 Carbogen Hypoxia Murine tumor ^32P-colloid interstitial treatment Effect
  • 相关文献

参考文献11

二级参考文献30

  • 1陈炳桓 邵文钊 等.实验性小鼠胶质瘤的诱发和G422胶质母细胞瘤瘤株的建立[J].北京医学,1981,3:15-19. 被引量:4
  • 2王大章,华西口腔医学杂志,1991年,9卷,138页 被引量:1
  • 3毛慧生,中国放射肿瘤学杂志,1988年,2卷,34页 被引量:1
  • 4朱承谟,中华核医学杂志,1999年,19卷,1页 被引量:1
  • 5陈炳桓,北京医学,1981年,3卷,15页 被引量:1
  • 6Fukumura D, Xu L, Chen Y, et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res, 2001, 61(16):6020-6024. 被引量:1
  • 7Vordermark D, Shibata T, Brown JM. Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation. Neoplasia, 2001, 3(6):527-534. 被引量:1
  • 8Ray P, Bauer E, Iyer M,et al. Monitoring gene therapy with reporter gene imaging. Semin Nucl Med, 2001, 31(4):312-320. 被引量:1
  • 9Luna MC, Chen X, Wong S, et al. Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter. Cancer Res, 2002,62(5):1458-1461. 被引量:1
  • 10Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001, 49(4):1171-1182. 被引量:1

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部